Byung Soo Kwan; Jeong Han Kim; Seong Jun Park; Won Hyeok Choe; So Young Kwon; Byung-Chul Yoo
(The Korean Association Of Internal Medicine, 2021-03)
Background/Aims: Chronic hepatitis C (CHC) treatment has dramatically improved since direct-acting antiviral (DAA) therapy was introduced. However, the use of DAA therapy in CHC patients with hepatocellular carcinoma (HCC) ...